Ulcerative colitis trials in Poland

In Poland 48 Also abroad 382

48 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Bydgoszcz, Elblag, Katowice, Kłodzko, Krakow, Lublin, Opole, Poznan, Rzeszów, Sopot, Staszów, Szczecin, Torun, Wadowice, Warsaw, Wroclaw
Age
16 years to 80 years
People
751 worldwide
Run by
Sanofi
See details and how to joinNCT07185009
Phase 1Taking people
An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
Where
Bydgoszcz, Lodz, Lublin, Nowy Targ, Pabianice, Poznan, Warsaw, Wroclaw
Age
18 years to 60 years
People
25 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07665723 · EU 2025-524060-38-00
Phase 3Taking people
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Cracow, Rzeszów, Warsaw, Zabrze
Age
2 years to 17 years
People
70 worldwide
Run by
Takeda
See details and how to joinNCT06405087 · EU 2023-508804-39-00
Phase 2Taking people
LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study
Where
Katowice, Piotrkow Trybunalski, Poznan, Szczecin, Warsaw, Zamość
Age
18 years and over
People
75 worldwide
Run by
Eli Lilly & Co.
See details and how to join2025-522338-30-00 · EU 2025-522338-30-00
Phase 3Taking people
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Where
Rzeszów, Szczecin, Warsaw, Wroclaw
Age
2 years to 19 years
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT04844606
Phase 2Taking people
Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Where
Bydgoszcz, Katowice, Krakow, Lodz, Lublin, Oswiecim, Poznan, Rzeszów, Sopot, Warsaw, Wroclaw
Age
18 years to 75 years
People
120 worldwide
Run by
Athos Therapeutics Inc
See details and how to joinNCT07513181 · EU 2024-520183-33-00
Phase 2Taking people
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Where
Krakow, Lublin, Pabianice, Poznan, Rzeszow, Sopot, Szczecin, Torun, Warsaw, Włocławek, Wroclaw, Zamość
Age
18 years to 80 years
People
80 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06636656 · EU 2023-509544-10-00
Phase 2Taking people
Comparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis – the head-to-head COMBO-UC trial.
Where
Bydgoszcz, Katowice, Krakow, Lodz, Lublin, Poznan, Warsaw
Age
18 years to 64 years
People
172
Run by
Medical University Of Lodz
See details and how to join2023-506452-25-00 · EU 2023-506452-25-00
Early phase 1Enrolling by invitation
VIBRANT-IBD: Brain Effects of Non-Invasive Vagus Nerve Stimulation in IBD Remission
Where
Gdansk
Age
18 years and over
People
15
Run by
University of Gdansk
See details and how to joinNCT07636304
Phase 1Not yet taking people in Poland
A Randomized, Double-Blind, Placebo Controlled, Multi - Center, Phase 1b Study to Evaluate the Safety and Tolerability of LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis
Where
Rzeszow, Warsaw, Wroclaw
Age
18 years to 64 years
People
8
Run by
Medytox Inc.
See details and how to join2024-514520-16-00 · EU 2024-514520-16-00
Phase 3Taking people
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Where
Cracow, Rzeszów, Warsaw, Zabrze
Age
2 years to 17 years
People
70 worldwide
Run by
Takeda
See details and how to joinNCT06100289 · EU 2023-503188-40-00
Phase 2Taking people
A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Where
Bydgoszcz, Chojnice, Katowice, Rzeszow, Sopot, Staszów, Warsaw, Wroclaw
Age
18 years and over
People
70 worldwide
Run by
Odyssey Therapeutics Inc.
See details and how to join2024-520201-39-00 · EU 2024-520201-39-00
Phase 2/3Taking people
A phase 2/3, multicenter, randomized, double-blind study to evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of oral ozanimod (RPC1063) in pediatric subjects with moderately to severely active ulcerative colitis with an inadequate response to conventional therapy.
Where
Lodz, Szczecin, Warsaw, Wroclaw
Age
Up to 17 years
People
62 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-509248-86-00 · EU 2023-509248-86-00
Phase 2Taking people
A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease
Where
Bydgoszcz, Katowice, Lodz, Poznan, Sopot, Staszów, Szczecin, Tychy, Warsaw, Wroclaw
Age
18 years and over
People
54 worldwide
Run by
Mirador Therapeutics Inc.
See details and how to join2025-522001-38-00 · EU 2025-522001-38-00
Phase 2Taking people
Evaluation of the efficacy and safety of dual biologic and/or small molecule therapy in patients with induction-resistant ulcerative colitis (RESPECT).
Where
Sosnowiec, Szczecin, Warsaw
Age
18 years and over
People
180
Run by
Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy
See details and how to join2023-506628-98-00 · EU 2023-506628-98-00
Phase 2Taking people
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Where
Bydgoszcz, Lodz, Lublin, Rzeszow, Rzeszów, Szczecin, Torun, Tychy, Warsaw, Wroclaw, Wrocław, Zamość
Age
18 years to 75 years
People
192 worldwide
Run by
Takeda
See details and how to joinNCT06764615 · EU 2024-518914-18-00
No phaseTaking people
Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD)
Where
Warsaw
Age
18 years to 80 years
People
6,000
Run by
Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji
See details and how to joinNCT07593352
Phase 3Taking people
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Cracow, Lodz, Rzeszów, Szczecin, Warsaw
Age
2 years to 17 years
People
240 worldwide
Run by
Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00
Phase 2Taking people
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Where
Bydgoszcz, Chojnice, Katowice, Rzeszów, Sopot, Staszów, Warsaw, Wroclaw
Age
18 years to 75 years
People
57 worldwide
Run by
Odyssey Therapeutics, Inc.
See details and how to joinNCT06850727
No phaseTaking people
Microplastic Analysis in Pediatric Inflammatory Bowel Disease
Where
Gdansk
Age
Up to 18 years
People
40
Run by
Medical University of Gdansk
See details and how to joinNCT07141238
Phase 2Taking people
Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis
Where
Lodz
Age
18 years to 64 years
People
172
Run by
Medical University of Lodz
See details and how to joinNCT06453317
Phase 1Not yet taking people in Poland
LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis (UC)
Where
Wroclaw
Age
18 years to 65 years
People
15
Run by
Liveome Inc.
See details and how to joinNCT06749795
Phase 2Taking people
This is a multicenter, double-blind, randomized study to compare the safety, effectiveness and immunogenicity (level and body resistance to drugs) of two biological drugs administered intravenously - vedolizumab (a drug not registered in pediatric patients) and infliximab (used as standard therapy) in pediatric patients with ulcerative colitis aged 6-17 years.
Where
Białystok, Gdańsk, Katowice, Lodz, Lublin, Rzeszów, Toruń, Warsaw, Wrocław, Zabrze
Age
Up to 17 years
People
66
Run by
Instytut Pomnik Centrum Zdrowia Dziecka
See details and how to join2023-509775-16-00 · EU 2023-509775-16-00